ALPS Medical Breakthroughs ETF (SBIO)
| Assets | $95.39M |
| Expense Ratio | 0.50% |
| PE Ratio | n/a |
| Shares Out | 3.10M |
| Dividend (ttm) | $1.17 |
| Dividend Yield | 3.79% |
| Ex-Dividend Date | Dec 19, 2024 |
| Payout Ratio | n/a |
| 1-Year Return | -3.81% |
| Volume | 5,283 |
| Open | 31.08 |
| Previous Close | 30.81 |
| Day's Range | 30.92 - 31.08 |
| 52-Week Low | 30.07 |
| 52-Week High | 42.73 |
| Beta | 0.88 |
| Holdings | 106 |
| Inception Date | Dec 31, 2014 |
About SBIO
Fund Home PageThe ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is issued by SS&C.
Top 10 Holdings
30.22% of assets| Name | Symbol | Weight |
|---|---|---|
| Alkermes plc | ALKS | 3.99% |
| Axsome Therapeutics, Inc. | AXSM | 3.73% |
| Verona Pharma plc | VRNA | 3.55% |
| Crinetics Pharmaceuticals, Inc. | CRNX | 2.90% |
| Avidity Biosciences, Inc. | RNA | 2.89% |
| PTC Therapeutics, Inc. | PTCT | 2.83% |
| Rhythm Pharmaceuticals, Inc. | RYTM | 2.80% |
| Denali Therapeutics Inc. | DNLI | 2.64% |
| Xenon Pharmaceuticals Inc. | XENE | 2.46% |
| ACADIA Pharmaceuticals Inc. | ACAD | 2.44% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 19, 2024 | $1.174 | n/a |
| Dec 21, 2023 | $0.071 | Dec 27, 2023 |
| Dec 19, 2019 | $0.016 | Dec 27, 2019 |
| Dec 20, 2018 | $0.784 | Dec 27, 2018 |
| Dec 21, 2017 | $0.579 | Dec 28, 2017 |
News
SBIO ETF: Betting On Medical Breakthroughs
ALPS Medical Breakthroughs ETF is rated Hold due to high fees, low yield, and mixed performance compared to other healthcare ETFs. The SBIO ETF focuses on small and mid-cap biotech companies with drug...
Biotech Looms as a Way to Beat the Market
Could now be the time to diversify into important tech subsectors? Rate cuts may already be benefiting tech sectors by easing borrowing costs, with more cuts potentially in the offing.
Disruptive Theme of the Week – Breakthroughs in Medicine
Medical breakthroughs are occurring constantly, but they often get lost in the news headlines unless they directly impact our lives. I wanted to take a moment to highlight a few recent medical breakth...
Advacam & Vector Space Biosciences sign Letter of Intent (LOI) to Develop AI Models & CubeSat Payloads for the Space Industry
LA JOLLA, Calif.--(BUSINESS WIRE)---- $SBIO #Advacam--Advacam, provider of radiation detectors that map radiation aboard the International Space Station (ISS) and Vector Space Biosciences (crypto symb...
Vector Space Biosciences (SBIO) Is Now Available for Trading on LBank Exchange
Road Town, Virgin Islands--(Newsfile Corp. - September 24, 2023) - LBank Exchange, a global digital asset trading platform, listed Vector Space Biosciences (SBIO) on September 15, 2023. For all users ...
